HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the article, please login or register as reader.

2022

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 5 - 19)

Exploration of the physical health of dual users of heroin and crack in methadone treatment who inject or have previously injected drugs

Heidebrecht F., Macleod M.B., and Dawkins L.

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 21 - 29)

Patterns of new psychoactive substance use among opioid-dependent patients attending for opioid agonist treatment

McCarron P., Smyth B., Carroll G., Glynn M., Barry J., Whiston L., Keenan E., Darker C., and Truszkowska E.

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 31 - 38)

The Role of Familial and Cultural Factors in Relapse of Methadone Maintenance Treated Patients

Badiei R., Motazedian S., Kheradmand A., and Seif P.

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 39 - 45)

Effects of family functions on opioid use disorder patients to remission

Sahiner I.V., Kir Y., and Sahiner S.

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 47 - 52)

Sexual dysfunction in patients with opioid use disorder: a comparison between naltrexone implant and buprenorphine/naloxone maintenance treatment

Caliskan A.M., and Yildiz M.C.

Heroin Addiction and Related Clinical Problems: 2022, 24, N1 (pages: 53 - 63)

Characteristics of foreign drug addicts assisted by Addiction Centre in Naples, Italy

Curcio F., Asturaro E., Bandiera F., Barretta V., Fontebasso M., Gautiero G., Rutigliano M.A., Girasole D., Marguccio E., Marsella E., Mazzella C., Nicotra F., Pianese P., Preziuso M., Procida M., Spalice A., Scialò L., and Topa M.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 5 - 12)

Buprenorphine-Naloxone abuse among Participants in the needle exchange programme. A Finnish Time-Trend Study from 2008 to 2018.

Fältberg N., Partanen M., Lintonen T., Mishina K., and Niemelä S.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 13 - 17)

Patient Satisfaction with Telemedicine in Addictions

Mayet S., Arshad S., McCaw I., Hashmani Z., Drozdova Z., Gledhill A., Shahbaz S., and Phillips T.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 19 - 25)

Real-world retention rates with a long-acting buprenorphine depot in opioid-dependent patients attending private clinics in Australia.

MacDonald T., Connor P., Edwards J., Hardy M., Kemp D., and Johnston L.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 27 - 34)

Relapse rate following institutionalized rehabilitation of male heroin addicts: A Sri Lankan experience

Darshana N., Wijesinghe C., and De Silva V.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 35 - 44)

Prevalence of Suboptimal Dosing of Methadone and Buprenorphine and Associated Factors in Opioid Dependent Patients

Al-Dewaissan F.B.A.A., Hill D.R., Evans L., and Luz T.C.B.

Heroin Addiction and Related Clinical Problems: 2022, 24, N2 (pages: 45 - 51)

Exploring impaired insight in opioid addiction: the role of self-stigma

Eidenmueller K., Grimm F., Hermann D., Frischknecht U., Kiefer F., Dziobek I., and Bekier N.K.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 5 - 12)

Trends in Cigarette Smoking among Italian Substance Use Disorder Patients

Miccoli M., Poli A., Maremmani A.G.I., Della Rocca F., Pani P.P., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 13 - 19)

Results of a survey among opioid addiction treatment providers on the importance of physical exercise

Spitzer U., Meyer M., Guggisberg E., Mirek K., Walter M., and Dursteler K.M.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 21 - 27)

Baclofen in the Treatment of Alcohol Withdrawal Syndrome in Opioid-Dependent Patients

Gibbons Z., McCarron P., Santlal K., McCarthy R., and Keenan E.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 29 - 32)

Improving Attendance in Addictions. Do Quality Improvement Plans Work?

Mayet S., Shahbaz S., and Arshad S.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 33 - 40)

Opium use and risk of stroke: a systematic review and meta-analysis

Borhani-Haghighi A., Tabrizi R., Estakhr M., Hosseini-Bensenjan M., Niknam M., Iravani Saadi M., Moazzen F., and Nowrouzi-Sohrabi P.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 41 - 45)

Challenges and solutions for opioid dependence therapy during the SARS-CoV-2 pandemic in Germany

Poehlke T.

Heroin Addiction and Related Clinical Problems: 2022, 24, N3 (pages: 47 - 55)

P300 Event-Related Potentials as a Marker of Craving in Opioid Use Disorder: a Systematic Literature Review

Skrenes A., Labonté L.E., Muñoz-Violant S., Khehra J., Krigolson O., and Schütz C.

Heroin Addiction and Related Clinical Problems: 2022, 24, N4 (pages: 5 - 18)

Pilot study using long acting injectable buprenorphine (LAIB) as a novel treatment option in NHS Lanarkshire Addiction Services in Scotland

Stewart E., Marr E., and Hill D.

Heroin Addiction and Related Clinical Problems: 2022, 24, N4 (pages: 19 - 25)

How to Assess Visibility of Drug-Related Stigmatized Behaviours? Does the Choice of Method Matter?

Rastegari A., Haghdoost A., Mehrolhassani M.H., Azizian M., HajiMaghsoudim S., and Baneshi M.R.

Heroin Addiction and Related Clinical Problems: 2022, 24, N4 (pages: 27 - 32)

Nutritional status of patients in methadone, buprenorphine, and opium tincture maintenance therapy

Kheradmand A., Samani N., and Fazeli A.

Heroin Addiction and Related Clinical Problems: 2022, 24, N4 (pages: 33 - 39)

Prescription opioids use and opioid-related mortality monitoring in Slovenia

Kostnapfel T., Jandl M., Hočevar Grom A., Korošec A., and Kastelic A.

Heroin Addiction and Related Clinical Problems: 2022, 24, N4 (pages: 41 - 46)

Quality of life differential changes from psychopathological episodes through recovery in Heroin Addiction

Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 5 - 6)

Quantitative methods in addiction research. The role of the Addiction Research Methods Institute

Miccoli M.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 7 - 15)

Suboptimal dosing of opioid agonist treatments - a Literature Review

Al-Dewaissan F.B.A.A., Hill D., Evans L., and Luz T.C.B.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 17 - 25)

Problematic Level of Drug Use and its associated factors among Illicit Drug Users in Sri Lanka: Experience from a Multicentre Study

Darshana N., Wijesinghe C., and De Silva V.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 27 - 35)

Automated Responses to Opioid-Related Cues as a Dysregulated Allostatic Oxytocin Response: A Short Review

Houghton B.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 37 - 41)

Hedonic Capacity in Individuals Treated with Medications for Opioid Use Disorder

Wenzel K., Thomas J., Carrano J., Severino A., and Fishman M.

Heroin Addiction and Related Clinical Problems: 2022, 24, N5 (pages: 43 - 50)

Can the Psychopathology Specific to Substance Use Disorder Distinguish between Recreational Cocaine Use and Cocaine Addiction?

Della Rocca F., Maremmani A.G.I., Bacciardi S., Miccoli M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 5 - 14)

Impact of opium tincture and exercise in the management of opioid withdrawal: Assessing behavioural and neuroendocrine changes in Opioid Use Disorder patients

Bavisi M., Tirdad R., Ghorbani R., Shafia S., Hajirasouli M., and Miladi-Gorji H.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 15 - 23)

Reasons behind Use of Heroin and Stimulants: A Functional Perspective

Zhao Q., Hongyu G., and Mao Y.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 25 - 32)

New insights from Observational Retrospective Study on Tolerability of Levomethadone in Patients with Opioid Use Disorder

Sacco S., Barciocco D., Mussi D., and Bartoletti L.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 33 - 43)

Opium use and risk of upper gastrointestinal cancers: A systematic review and meta-analysis

Manafi A., Hosseini S., Kashani S.M.A., Owrangi S., Ahmadipour A., Salahi S., and Akbari H.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 45 - 50)

Image rehearsal therapy as a treatment for nightmares within substance-dependence populations

Flores C., and Riaz U.

Heroin Addiction and Related Clinical Problems: 2022, 24, N6 (pages: 51 - 55)

Problem Tree Force Field Analysis of injection of opioid agonist therapy and benzodiazepines in North Macedonia

Ignjatova L.A.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page